| Long name: |
Recombinant Human alpha-2-HS-glycoprotein (AHSG) Protein |
| Type: |
Recombinant protein |
| Knowledgebase of uniprot: |
Ala19-Val368 (P02765) |
| Gene name synonym: |
Alpha-2-HS-glycoprotein, AHSG, FETUA |
| Purification: |
Greater than 95% (SDS-PAGE analysis) |
| Examined analyses: |
ELISA, Western blotting |
| Expressed in: |
Escherichia coli |
| KiloDaltons of the protein: |
38 kDa |
| Storage conditions: |
For long termstorage, The cycles of freezing and thawing are not recommended as such cycles can damage the structure of the polypeptide chains, freeze and keep at -20°, please, C, C for up to one month, Human alpha-2-HS-glycoprotein (AHSG) Protein can be refrigerated at +4° |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
alpha-2-HS-glycoprotein (AHSG) Protein |
| Short name: |
alpha-2-HS-glycoprotein (AHSG) Protein |
| Species: |
Humans, Human |
| Alternative name: |
sapiens a-2-HS-glycoprotein (alpha-2-HS-glycoprotein) Protein, H |
| Alternative to gene target: |
A2HS and AHS and FETUA and HSGA, AHSG and IDBG-634683 and ENSBTAG00000000522 and 280988, AHSG and IDBG-68916 and ENSG00000145192 and 197, Ahsg and IDBG-148706 and ENSMUSG00000022868 and 11625, Extracellular, kinase inhibitor activity, this GO :0001501 and skeletal system development and biological process this GO :0001503 and ossification and biological process this GO :0004869 and cysteine-type endopeptidase inhibitor activity and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006907 and pinocytosis and biological process this GO :0006953 and acute-phase response and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0019210 and kinase inhibitor activity and molecular function this GO :0030500 and regulation of bone mineralization and biological process this GO :0030502 and negative regulation of bone mineralization and biological process this GO :0042326 and negative regulation of phosphorylation and biological process this GO :0045087 and innate immune response and biological process this GO :0046627 and negative regulation of insulin receptor signaling pathway and biological process this GO :0050727 and regulation of inflammatory response and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component, this GO :0004869 : cysteine-type endopeptidase inhibitor activity, this GO :0004869 : cysteine-type endopeptidase inhibitor activity and also this GO :0019210 : kinase inhibitor activity, this GO :0019210 : kinase inhibitor activity, alpha-2-HS-glycoprotein |
| Identity: |
349 |
| Gene: |
AHSG |
More about : AHSG |
| Long gene name: |
alpha 2-HS glycoprotein |
| Synonyms: |
FETUA A2HS HSGA |
| Synonyms name: |
fetuin A |
| Locus: |
3q27, 3 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
D67013 M16961 |
| Entrez gene record: |
197 |
| Pubmed identfication: |
9322749 7736783 |
| RefSeq identity: |
NM_001622 |
| Classification: |
Cystatins, type 4 |
| Havana BLAST/BLAT: |
OTTHUMG00000156605 |